{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:20:52Z","timestamp":1777562452002,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12288-014-0402-4","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T00:41:11Z","timestamp":1399941671000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report"],"prefix":"10.1007","volume":"31","author":[{"given":"Habip","family":"Gedik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner","family":"Y\u0131ld\u0131rmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Kant\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demet","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naciye","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Yoku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Ar\u0131ca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"key":"402_CR1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al (2011) Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:56\u201393","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"402_CR2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/383050","volume":"39","author":"J Klastersky","year":"2004","unstructured":"Klastersky J (2004) Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 39(Suppl 1):32\u201337","journal-title":"Clin Infect Dis"},{"key":"402_CR3","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038\u20133051","journal-title":"J Clin Oncol"},{"key":"402_CR4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/annonc\/mdq196","volume":"21","author":"J Naurois de","year":"2010","unstructured":"de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F (2010) Management of febrile neutropenia: ESMO clinical practice guidelines. Ann Oncol 21:252\u2013256","journal-title":"Ann Oncol"},{"key":"402_CR5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel R, Edmond M (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103\u20131110","journal-title":"Clin Infect Dis"},{"key":"402_CR6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","volume":"66","author":"C Gudiol","year":"2011","unstructured":"Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sa\u00b4nchez-Ortega I, Duarte R, Calvo M, Carratal\u00e0 J (2011) Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 66:657\u2013663","journal-title":"J Antimicrob Chemother"},{"key":"402_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex HB, De Pauw B, Bennett JE, Bille J, Crokaert F et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7\u201314","journal-title":"Clin Infect Dis"},{"key":"402_CR8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730\u2013751","journal-title":"Clin Infect Dis"},{"key":"402_CR9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.1996.14.2.636","volume":"14","author":"JY Blay","year":"1996","unstructured":"Blay JY, Chauvin F, Le Cesne A, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, Biron P (1996) Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol 14:636","journal-title":"J Clin Oncol"},{"key":"402_CR10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s150100070007","volume":"28","author":"TA Madani","year":"2000","unstructured":"Madani TA (2000) Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leucemia. Infection 28:367\u2013371","journal-title":"Infection"},{"issue":"2","key":"402_CR11","first-page":"362","volume":"13","author":"H Gedik","year":"2013","unstructured":"Gedik H, Yildirmak T, Simsek F, Kanturk A, Ayd\u0131n D, Ar\u0131ca D et al (2013) The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies. Afr Health Sci 13(2):362\u2013368","journal-title":"Afr Health Sci"},{"key":"402_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1179\/joc.2010.22.1.5","volume":"22","author":"J Mebis","year":"2010","unstructured":"Mebis J, Goossens H, Berneman Z (2010) Antibiotic management of febrile neutropenia: current developments and future directions. J Chemother 22:5\u201312","journal-title":"J Chemother"},{"issue":"2","key":"402_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bjid.2012.09.010","volume":"17","author":"G Metan","year":"2013","unstructured":"Metan G, Demiraslan H, Kaynar LG, Zarars\u0131z G, Alp E, Eser B (2013) Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases. Braz J Infect Dis 17(2):143\u2013149","journal-title":"Braz J Infect Dis"},{"issue":"4","key":"402_CR14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bjid.2012.06.009","volume":"16","author":"FF Tuon","year":"2012","unstructured":"Tuon FF, Gortz LW, Rocha JL (2012) Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy. Braz J Infect Dis 16(4):351\u2013356","journal-title":"Braz J Infect Dis"},{"issue":"10","key":"402_CR15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1086\/656247","volume":"31","author":"LS Munoz-Price","year":"2010","unstructured":"Munoz-Price LS, Zembower T, Penugonda S, Schreckenberger P, Lavin MA, Welbel S et al (2010) Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. Infect Control Hosp Epidemiol 31(10):1057\u20131062","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"402_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s15010-010-0008-1","volume":"38","author":"C Routsi","year":"2010","unstructured":"Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, Vrettou C, Paniara O, Giamarellou H, Roussos C (2010) Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 38(3):173\u2013180","journal-title":"Infection"},{"issue":"15","key":"402_CR17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.medcli.2011.06.024","volume":"138","author":"Hern\u00e1ndez-Torres","year":"2012","unstructured":"Hern\u00e1ndez-Torres, Garc\u00eda-V\u00e1zquez E, G\u00f3mez J, Canteras M, Ruiz J, Yag\u00fce G\u00a0(2012) Multidrug and carbapenem-resistant Acinetobacter baumannii infections: factors associated with mortality. Med Clin (Barc) 138(15):650\u2013655","journal-title":"Med Clin (Barc)"},{"key":"402_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1592\/phco.23.12.1232.32706","volume":"23","author":"DS Burgess","year":"2003","unstructured":"Burgess DS, Hall RG II, Lewis JS II, Jorgensen JH, Patterson JE (2003) Clinical and microbiologic analysis of a hospital\u2019s extended-spectrum beta-lactamase-producing isolates over a 2-year period. Pharmacotherapy 23:10","journal-title":"Pharmacotherapy"},{"issue":"7","key":"402_CR19","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.01523-12","volume":"57","author":"FN Frakking","year":"2013","unstructured":"Frakking FN, Rottier WC, Dorigo-Zetsma JW, van Hattem JM, van Hees BC, Kluytmans JA et al (2013) Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum \u03b2-lactamase producing bacteria. Antimicrob Agents Chemother 57(7):3092\u20133099","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"402_CR20","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbmt.2010.05.008","volume":"16","author":"M Kamboj","year":"2010","unstructured":"Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA, Papanicolaou G (2010) The changing epidemiology of vancomycin-resistant enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 16(11):1576\u20131578","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"402_CR21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajic.2006.04.205","volume":"34","author":"MJ Matar","year":"2006","unstructured":"Matar MJ, Tarrand J, Raad I, Rolston KV (2006) Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34(8):534\u2013536","journal-title":"Am J Infect Control"},{"key":"402_CR22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.7326\/0003-4819-136-11-200206040-00013","volume":"136","author":"N Safdar","year":"2002","unstructured":"Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136:444\u2013834","journal-title":"Ann Intern Med"},{"key":"402_CR23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/172.4.993","volume":"172","author":"DK Shay","year":"1995","unstructured":"Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, Bland LA, Jarvis WR (1995) Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 172:993\u20131000","journal-title":"J Infect Dis"},{"key":"402_CR24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1086\/501561","volume":"20","author":"MJ Kuehnert","year":"1999","unstructured":"Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR (1999) Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized patients. Infect Control Hosp Epidemiol 20:660\u2013663","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"402_CR25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/clinids\/23.6.1234","volume":"23","author":"MB Edmond","year":"1996","unstructured":"Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP (1996) Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 23(6):1234\u20131239","journal-title":"Clin Infect Dis"},{"issue":"Supplement 1","key":"402_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/383042","volume":"39","author":"A Kanamaru","year":"2004","unstructured":"Kanamaru A, Tatsumi Y (2004) Microbiological data for patients with febrile neutropenia. Clin Infect Dis 39(Supplement 1):7\u201310","journal-title":"Clin Infect Dis"},{"key":"402_CR27","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00520-007-0398-5","volume":"16","author":"PG Morris","year":"2008","unstructured":"Morris PG, Hassan T, McNamara M, Hassan A, Wiig R, Grogan L et al (2008) Emergence of MRSA in positive blood cultures from patients with febrile neutropenia\u2014a cause for concern. Support Care Cancer 16:1085\u20131088","journal-title":"Support Care Cancer"},{"key":"402_CR28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/514695","volume":"27","author":"E Girou","year":"1998","unstructured":"Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C (1998) Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 27:543\u2013550","journal-title":"Clin Infect Dis"},{"key":"402_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/501655","volume":"20","author":"G Papia","year":"1999","unstructured":"Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE (1999) Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 20:473\u2013477","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-014-0402-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-014-0402-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-014-0402-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T07:34:14Z","timestamp":1565422454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-014-0402-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1007\/s12288-014-0402-4","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}